• Relative Articles

    [1] Lin WANG, Lingjun SHEN, Haiwen LI, Xiaoyan WANG, Jianpeng GAO, Zhiqiang MA. Analysis of Nutritional Status and Immune Function of Tuberculosis Patients in Yunnan. Journal of Kunming Medical University, 2023, 44(1): 109-115.  doi: 10.12259/j.issn.2095-610X.S20230116
    [2] Nihong LU, Honglu LIU, Yangjun CHEN, Meiyan LIU, Yongrui YANG, Yingrong DU. Analysis of Characteristic Indexes of Liver Injury Model Induced by Different Antituberculosis Drugs in Mice. Journal of Kunming Medical University, 2023, 44(6): 6-13.  doi: 10.12259/j.issn.2095-610X.S20230615
    [3] Yang Li Wei . . Journal of Kunming Medical University,
    [4] Wang Guo Liang . . Journal of Kunming Medical University,
    [5] Yin Jia Fu . . Journal of Kunming Medical University,
    [6] Xing Wen Zhong . . Journal of Kunming Medical University,
    [7] Zhu Yan Ping . . Journal of Kunming Medical University,
    [8] Shi Chao Kai . . Journal of Kunming Medical University,
    [9] Zhang Yan . . Journal of Kunming Medical University,
    [10] Li Jin Tao . . Journal of Kunming Medical University,
    [11] Shang Yan Xia . . Journal of Kunming Medical University,
    [12] Lu Ni Hong . Clinical Characteristics of Pulmonary Tuberculosis Patients with and without HIV(+)/AIDS. Journal of Kunming Medical University,
    [13] Long Zhi Ren . . Journal of Kunming Medical University,
    [14] Chen Jin . . Journal of Kunming Medical University,
    [15] Rui Zhang Ru . . Journal of Kunming Medical University,
    [16] Liu Qiong . . Journal of Kunming Medical University,
    [17] . . Journal of Kunming Medical University,
    [18] Zhang Min . . Journal of Kunming Medical University,
    [19] . The Cause Analysis on the Failure of Tumor Cells Culture from Malignant Hydrothorax. Journal of Kunming Medical University,
    [20] Han Rui Ping . Surveillance of Arsenic Pollution in Yangzonghai Lake in Recent Three Years. Journal of Kunming Medical University,
  • Cited by

    Periodical cited type(6)

    1. 丁妍华,门帅,张江霞,张旭,张善存,刘璐,吕宏伟,肖正红. 贝伐珠单抗联合安罗替尼治疗非小细胞肺癌的临床疗效及对免疫状态的影响. 哈尔滨医药. 2024(01): 41-44 .
    2. 解燕茹. 安罗替尼联合伊立替康和洛铂二线治疗晚期小细胞肺癌的临床研究. 基层医学论坛. 2024(07): 51-53 .
    3. 张全,曹志坤,丁成智,刘孟博,李基伟,魏立. 安罗替尼通过核因子信号通路抑制非小细胞肺癌细胞增殖、迁移和侵袭并促进细胞凋亡. 中华实验外科杂志. 2024(12): 2778-2782 .
    4. 王帅,刘景春. 安罗替尼联合TC化疗方案治疗驱动基因阴性晚期肺腺癌患者的效果. 河南医学研究. 2023(05): 912-916 .
    5. 林征,周进,黄开荣. 安罗替尼联合AN方案一线治疗晚期野生型肺腺癌的回顾性研究. 中国医学创新. 2023(31): 32-37 .
    6. 马闻. 替雷利珠单抗联合安罗替尼治疗晚期肺腺癌的效果及对血清肿瘤标志物的影响. 中国医学创新. 2022(17): 124-127 .

    Other cited types(1)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04050100150
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 26.8 %FULLTEXT: 26.8 %META: 72.8 %META: 72.8 %PDF: 0.4 %PDF: 0.4 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 3.9 %其他: 3.9 %China: 5.1 %China: 5.1 %United States: 0.0 %United States: 0.0 %上海: 8.2 %上海: 8.2 %东莞: 0.1 %东莞: 0.1 %六安: 0.1 %六安: 0.1 %内华达州: 0.0 %内华达州: 0.0 %北京: 31.7 %北京: 31.7 %南京: 0.1 %南京: 0.1 %南平: 0.1 %南平: 0.1 %哥伦布: 0.1 %哥伦布: 0.1 %宜春: 0.1 %宜春: 0.1 %广州: 0.1 %广州: 0.1 %张家口: 0.4 %张家口: 0.4 %拉萨: 0.0 %拉萨: 0.0 %无锡: 0.3 %无锡: 0.3 %昆明: 0.1 %昆明: 0.1 %杭州: 0.0 %杭州: 0.0 %武汉: 0.0 %武汉: 0.0 %深圳: 0.1 %深圳: 0.1 %绍兴: 0.2 %绍兴: 0.2 %芒廷维尤: 1.9 %芒廷维尤: 1.9 %西宁: 3.0 %西宁: 3.0 %贵阳: 0.0 %贵阳: 0.0 %贺州: 0.0 %贺州: 0.0 %邯郸: 0.0 %邯郸: 0.0 %郑州: 0.6 %郑州: 0.6 %长治: 0.0 %长治: 0.0 %驻马店: 43.5 %驻马店: 43.5 %其他ChinaUnited States上海东莞六安内华达州北京南京南平哥伦布宜春广州张家口拉萨无锡昆明杭州武汉深圳绍兴芒廷维尤西宁贵阳贺州邯郸郑州长治驻马店

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2597) PDF downloads(406) Cited by(7)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return